OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors
Brahe, C.H., Krabbe, S., Østergaard, M., Ørnbjerg, L., Glinatsi, D., Røgind, H., Jensen, H.S., Hansen, A., Nørregaard, J., Jacobsen, S., Terslev, L., Huynh, T.K., Jensen, D.V., Manilo, N., Asmussen, K., Frandsen, P.B., Boesen, M., Rastiemadabadi, Z., Carlsen, L.M., Møller, J., Krogh, N.S., Hetland, M.L.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
THU0189 One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the danbio registry
Glintborg, B., Sørensen, I.J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D.V., Nordin, H., Loft, A.G., Hendricks, O., Chrysidis, S., Andersen, B.L., Raun, J.L., Lindegaard, H., Espesen, J., Jakobsen, S.H., Hansen, I.M.J., Dalsgaard, E.B., Pedersen, D.D., Kristensen, S., Linauskas, A., Andersen, L.S., Grydehøj, J., Krogh, N., Hetland, M.L.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
FRI0103 One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. an observational danbio study
Glintborg, B., Sørensen, I.J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D.V., Nordin, H., Loft, A.G., Hendricks, O., Chrysidis, S., Andersen, B.L., Raun, J.L., Lindegaard, H., Espesen, J., Jakobsen, S.H., Hansen, I.M.J., Dalsgaard, E.B., Pedersen, D.D., Kristensen, S., Linauskas, A., Andersen, L.S., Grydehøj, J., Krogh, N.S., Hetland, M.L.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
AB0263 Agreement between Das28, Acr/eular, Sdai, Cdai and Ultrasound Remission in Patients with Rheumatoid Arthritis Receiving Biological Treatment in Routine Care
Brahe, C.H., Terslev, L., Krabbe, S., Østergaard, M., Røgind, H., Jensen, H.S., Hansen, A., Nørregaard, J., Jacobsen, S., Ellegaard, K., Fana, V., Juul, L., Huynh, T., Jensen, D., Manilo, N., Asmussen, K., Frandsen, P.B., Pedersen, S.T., Krogh, N.S., Hetland, M.L.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
OP0225 Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry
Glintborg, B., Juul Sørensen, I., Vendelbo Jensen, D., Krogh, N.S., Loft, A.G., Colic, A., Espesen, J., Olsen, J., Hendricks, O., Grydehøj, J., Hansen, I.M.J., Sørensen, M.V., Chrysidis, S., Manilo, N., Klarlund, M., Andersen, L.S., Nordin, H., Kristensen, S., Hetland, M.L.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
OP0075 Impact of Different Infliximab Dose Regimens on Treatment Response and Drug Survival in 462 Patients with PSA. Results from the Nationwide Registries Danbio and Icebio
Glintborg, B., Gudbjornsson, B., Krogh, N.S., Omerovic, E., Manilo, N., Holland-Fischer, M., Lindegaard, H., Loft, A.G., Nordin, H., Johnsen, L., Oeftiger, S.F., Hansen, A., Rasmussen, C., Grondal, G., Geirsson, A.J., Hetland, M.L.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article
OP0065 INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY
Nabi, H., Hetland, M. L., Loft, A. G., Hendricks, O., Jensen, D., Pedersen, J. K., Just, S. A., Danebod, K., Munk, H. L., Kristensen, S., Manilo, N., Colic, A., Linauskas, A., Thygesen, P. H., Christensen, L. B., Høgberget Kalisz, M., Lomborg, N., Grydehøj, J., Raun, J., Ahmed, R., Mehnert, F., Steen Krogh, N., Glintborg, B.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO
Glintborg, Bente, Gudbjornsson, Bjorn, Krogh, Niels Steen, Omerovic, Emina, Manilo, Natalia, Holland-Fischer, Mette, Lindegaard, Hanne M, Loft, Anne Gitte, Nordin, Henrik, Johnsen, Laura, Oeftiger, Sussi Flejsborg, Hansen, Annette, Rasmussen, Claus, Grondal, Gerdur, Geirsson, Arni Jon, Hetland, Merete Lund
Published in Rheumatology (Oxford, England) (01.11.2014)
Published in Rheumatology (Oxford, England) (01.11.2014)
Get full text
Journal Article
Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry
Ibfelt, Else Helene, Sørensen, Jan, Jensen, Dorte V, Dreyer, Lene, Schiøttz-Christensen, Berit, Thygesen, Pia H, Colic, Ada, Raun, Johnny L, Manilo, Natalia, Rødgaard, Anne, Poulsen, Uta E, Rasmussen, Claus, Hansen, Torben, Unger, Babara, Pelck, Randi, Kincses, Anita, Nordin, Henrik, Lorenzen, Tove, Theibich, Ali, Jensen Hansen, Inger Marie, Espesen, Jakob, Grydehøj, Jolanta, Holland-Fischer, Mette, Loft, Anne Gitte, Hetland, Merete Lund
Published in Clinical epidemiology (01.01.2017)
Published in Clinical epidemiology (01.01.2017)
Get full text
Journal Article
OP0225 Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry: Table 1
Glintborg, B., Juul Sørensen, I., Vendelbo Jensen, D., Krogh, N.S., Loft, A.G., Colic, A., Espesen, J., Olsen, J., Hendricks, O., Grydehøj, J., Hansen, I.M.J., Sørensen, M.V., Chrysidis, S., Manilo, N., Klarlund, M., Andersen, L.S., Nordin, H., Kristensen, S., Hetland, M.L.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry
Glintborg, B, Sørensen, IJ, Loft, AG, Esbesen, J, Lindegaard, H, Jensen, DV, Danebod, K, Dieperink, S, Hendricks, O, Hansen, IMJ, Linauskas, A, Kristensen, S, Andersen, LS, Hossein, M, Nordin, H, Andersen, BL, Chrysidis, S, Raun, JL, Manilo, N, Grydehøj, J, Dalgaard, EB, Pedersen, DD, Krogh, NS, Hetland, ML
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
OP0168 Clinical response, drug survival and predictors thereof in 432 patients with ankylosing spondylitis switching anti tumor necrosis factor [alpha] therapy: Results from the danish nationwide danbio registry
Glintborg, B, Østergaard, M, Krogh, N, Tarp, U, Loft, A, Hansen, A, Schlemmer, A, Fana, V, Kristensen, M, Lindegaard, H, Nordin, H, Rasmussen, C, Ejstrup, L, Petersen, PM, Manilo, N, Jensen, DV, Hetland, ML
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article